Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HLA‐B*35:01 and Green Tea–Induced Liver Injury
Jay H. Hoofnagle, Herbert L. Bonkovsky, Elizabeth J. Phillips, et al.
Hepatology (2020) Vol. 73, Iss. 6, pp. 2484-2493
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury
Naga Chalasani, Haripriya Maddur, Mark W. Russo, et al.
The American Journal of Gastroenterology (2021) Vol. 116, Iss. 5, pp. 878-898
Open Access | Times Cited: 267
Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis
Natsumi Hama, Riichiro Abe, Andrew Gibson, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 5, pp. 1155-1167.e5
Open Access | Times Cited: 139
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Robert J. Fontana, Iris Liou, Adrian Reuben, et al.
Hepatology (2022) Vol. 77, Iss. 3, pp. 1036-1065
Open Access | Times Cited: 115
Incidence and risk factors of drug‐induced liver injury
Xiaoyun Li, Jieting Tang, Yimin Mao
Liver International (2022) Vol. 42, Iss. 9, pp. 1999-2014
Closed Access | Times Cited: 90
The Evolving Profile of Idiosyncratic Drug-Induced Liver Injury
Robert J. Fontana, Einar S. Björnsson, K. Rajender Reddy, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 8, pp. 2088-2099
Open Access | Times Cited: 43
Liver Injury due to Intravenous Methylprednisolone in the Drug‐Induced Liver Injury Network
Jawad Ahmad, Yi‐Ju Li, Elizabeth J. Phillips, et al.
Liver International (2025) Vol. 45, Iss. 2
Open Access | Times Cited: 2
Liver Injury Associated with Turmeric—A Growing Problem: Ten Cases from the Drug-Induced Liver Injury Network [DILIN]
Dina Halegoua‐De Marzio, Victor J. Navarro, Jawad Ahmad, et al.
The American Journal of Medicine (2022) Vol. 136, Iss. 2, pp. 200-206
Open Access | Times Cited: 60
Tea consumption and attenuation of biological aging: a longitudinal analysis from two cohort studies
Yi Xiang, Hao Xu, Hongxiang Chen, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 42, pp. 100955-100955
Open Access | Times Cited: 29
Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injury
Naga Chalasani, Yi‐Ju Li, Andrew Dellinger, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 2, pp. 293-300
Open Access | Times Cited: 30
The Epidemiology of Newly Recognized Causes of Drug-Induced Liver Injury: An Update
Einar S. Björnsson
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 520-520
Open Access | Times Cited: 8
Drug-Induced Liver Injury in the Elderly: Consensus Statements and Recommendations from the IQ-DILI Initiative
Eric Cohen, Meenal Patwardhan, Ritu Raheja, et al.
Drug Safety (2024) Vol. 47, Iss. 4, pp. 301-319
Open Access | Times Cited: 7
Estimated Exposure to 6 Potentially Hepatotoxic Botanicals in US Adults
Alisa Likhitsup, Vincent Chen, Robert J. Fontana
JAMA Network Open (2024) Vol. 7, Iss. 8, pp. e2425822-e2425822
Open Access | Times Cited: 7
Challenges and Future of Drug-Induced Liver Injury Research—Laboratory Tests
Sabine Weber, Alexander L. Gerbes
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6049-6049
Open Access | Times Cited: 26
Hepatotoxicity due to herbal dietary supplements: Past, present and the future
Bill J. Gurley, Mitchell R. McGill, Igor Koturbash
Food and Chemical Toxicology (2022) Vol. 169, pp. 113445-113445
Open Access | Times Cited: 25
Complementary and alternative medicines and liver disease
Cyriac Abby Philips, Arif Hussain Theruvath, R. D. Ravindran, et al.
Hepatology Communications (2024) Vol. 8, Iss. 4
Open Access | Times Cited: 6
A comprehensive review on the hepatotoxicity of herbs used in the Indian (Ayush) systems of alternative medicine
Cyriac Abby Philips, Arif Hussain Theruvath
Medicine (2024) Vol. 103, Iss. 16, pp. e37903-e37903
Open Access | Times Cited: 6
Challenges in herbal‐induced liver injury identification and prevention
Dina Halegoua‐DeMarzio, Victor Navarro
Liver International (2024)
Open Access | Times Cited: 6
Recent advances in the diagnosis of drug-induced liver injury
Taqwa Ahmed, Jawad Ahmad
World Journal of Hepatology (2024) Vol. 16, Iss. 2, pp. 186-192
Open Access | Times Cited: 5
Drug‐induced liver injury (DILI) ascribed to non‐steroidal anti‐inflammatory drugs (NSAIDs) in the USA—Update with genetic correlations
Herbert L. Bonkovsky, Marwan Ghabril, Paola Nicoletti, et al.
Liver International (2024) Vol. 44, Iss. 6, pp. 1409-1421
Closed Access | Times Cited: 5
Garcinia cambogia, Either Alone or in Combination With Green Tea, Causes Moderate to Severe Liver Injury
Raj Vuppalanchi, Herbert L. Bonkovsky, Jawad Ahmad, et al.
Clinical Gastroenterology and Hepatology (2021) Vol. 20, Iss. 6, pp. e1416-e1425
Open Access | Times Cited: 32
Drug induced cholestatic liver diseases
Einar S. Björnsson, Harshad Devarbhavi
Hepatology (2024)
Closed Access | Times Cited: 4
Herbal and dietary supplement induced liver injury: Highlights from the recent literature
Stephanie Woo, William D. Davis, Soorya Aggarwal, et al.
World Journal of Hepatology (2021) Vol. 13, Iss. 9, pp. 1019-1041
Open Access | Times Cited: 25
New Insights into Herb-Induced Liver Injury
Zhi‐tao Ma, Zhuo Shi, Xiaohe Xiao, et al.
Antioxidants and Redox Signaling (2022) Vol. 38, Iss. 16-18, pp. 1138-1149
Open Access | Times Cited: 18
Harnessing nature's therapeutic potential: A review of natural products in prostate cancer management
Nicole A. Metri, Adel Mandl, Channing J. Paller
Urologic Oncology Seminars and Original Investigations (2025)
Closed Access
Risk factors and prediction for DILI in clinical practice
Helgi K. Björnsson, Einar S. Björnsson
Expert Opinion on Drug Metabolism & Toxicology (2025)
Closed Access
Page 1 - Next Page

Scroll to top